BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road) – FDA Inspection, Jan 25, 2024

Record Details

This FDA Inspection record concerns BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road), with an inspection on January 25, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)
Inspection Date: January 25, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Michael A. Charles (FDA Associated Person)

View Company Profile

ID · 9ec929dc-85be-48ed-a6b4-e48465ca7f38

Inspection Facts

Inspection number: 1227980
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)

FDA Inspection

BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)January 25, 2024